Literature DB >> 36090003

Post-partum female who woke up with hemiparesis.

Charles R Wira1, Evie Marcolini2, Ketan R Bulsara3.   

Abstract

Entities:  

Year:  2022        PMID: 36090003      PMCID: PMC9445425          DOI: 10.1002/emp2.12807

Source DB:  PubMed          Journal:  J Am Coll Emerg Physicians Open        ISSN: 2688-1152


× No keyword cloud information.

PATIENT PRESENTATION

A previously healthy 30‐year‐old female (2‐months post‐partum) woke up with right‐side hemiplegia and the inability to speak. She was last seen normal 8 hours prior by her husband before going to bed. Initial National Institutes of Health Stroke‐Scale Score (NIHSS) was 17. Acute brain imaging with magnetic resonance imaging (MRI) revealed restrictions of diffusion in the medial and posterior left middle cerebral artery (MCA) territory (core <70 cc) (Figure 1A) without corresponding fluid‐attenuated inversion recovery (FLAIR) signal abnormalities (Figure 1B). Acute vascular imaging revealed large vessel occlusions of the cervical/petrous segments of the left internal carotid artery and of the proximal left MCA.
FIGURE 1

Diffusion/FLAIR mismatch. Panel A, Diffusion‐Weighted Imaging (DWI) sequences with a restriction of diffusion (arrows show regions of early onset ischemia). Panel B, Fluid‐Attenuated Inversion Recoverey (FLAIR) sequences without any corresponding signal abnormalities.

Diffusion/FLAIR mismatch. Panel A, Diffusion‐Weighted Imaging (DWI) sequences with a restriction of diffusion (arrows show regions of early onset ischemia). Panel B, Fluid‐Attenuated Inversion Recoverey (FLAIR) sequences without any corresponding signal abnormalities.

DIAGNOSIS

Ischemic stroke with diffusion/FLAIR mismatch

The presence of a diffusion/FLAIR mismatch is indicative of stroke onset being less than 4.5 hours (Figure 1B). , Previous preliminary wake‐up stroke trials have used MRI to serve as the “witness” to when stroke onset begins and as an eligibility requirement for acute interventions (ie, thrombolysis). , MRI also demonstrated a small core (<70 cc) with a large territory of uninfarcted MCA territory, consistent with patient selection for thrombectomy in the extended time window. In our case, the patient was taken directly to the neuro‐cath lab for thrombectomy. Vessel flow was re‐established. Two days later, speech and power were significantly improved (NIHSS 7), and 4 weeks later the patient had no deficits.
  5 in total

1.  Thrombectomy for Stroke at 6 to 16 Hours with Selection by Perfusion Imaging.

Authors:  Gregory W Albers; Michael P Marks; Stephanie Kemp; Soren Christensen; Jenny P Tsai; Santiago Ortega-Gutierrez; Ryan A McTaggart; Michel T Torbey; May Kim-Tenser; Thabele Leslie-Mazwi; Amrou Sarraj; Scott E Kasner; Sameer A Ansari; Sharon D Yeatts; Scott Hamilton; Michael Mlynash; Jeremy J Heit; Greg Zaharchuk; Sun Kim; Janice Carrozzella; Yuko Y Palesch; Andrew M Demchuk; Roland Bammer; Philip W Lavori; Joseph P Broderick; Maarten G Lansberg
Journal:  N Engl J Med       Date:  2018-01-24       Impact factor: 91.245

2.  Sequence-specific MR imaging findings that are useful in dating ischemic stroke.

Authors:  Laura M Allen; Anton N Hasso; Jason Handwerker; Hamed Farid
Journal:  Radiographics       Date:  2012 Sep-Oct       Impact factor: 5.333

3.  Intravenous thrombolysis in unwitnessed stroke onset: MR WITNESS trial results.

Authors:  Lee H Schwamm; Ona Wu; Shlee S Song; Lawrence L Latour; Andria L Ford; Amie W Hsia; Alona Muzikansky; Rebecca A Betensky; Albert J Yoo; Michael H Lev; Gregoire Boulouis; Arne Lauer; Pedro Cougo; William A Copen; Gordon J Harris; Steven Warach
Journal:  Ann Neurol       Date:  2018-04-27       Impact factor: 10.422

4.  Implementation of emergent MRI for wake-up stroke: a single-center experience.

Authors:  Matthew H Kulzer; Warren Chang; Russell Cerejo; Charles Q Li; James Oskin; Michael Spearman; Ricardo Ochoa; Paul Aldinger; Michael F Goldberg
Journal:  Emerg Radiol       Date:  2021-06-30

5.  MRI-Guided Thrombolysis for Stroke with Unknown Time of Onset.

Authors:  Götz Thomalla; Claus Z Simonsen; Florent Boutitie; Grethe Andersen; Yves Berthezene; Bastian Cheng; Bharath Cheripelli; Tae-Hee Cho; Franz Fazekas; Jens Fiehler; Ian Ford; Ivana Galinovic; Susanne Gellissen; Amir Golsari; Johannes Gregori; Matthias Günther; Jorge Guibernau; Karl Georg Häusler; Michael Hennerici; André Kemmling; Jacob Marstrand; Boris Modrau; Lars Neeb; Natalia Perez de la Ossa; Josep Puig; Peter Ringleb; Pascal Roy; Enno Scheel; Wouter Schonewille; Joaquin Serena; Stefan Sunaert; Kersten Villringer; Anke Wouters; Vincent Thijs; Martin Ebinger; Matthias Endres; Jochen B Fiebach; Robin Lemmens; Keith W Muir; Norbert Nighoghossian; Salvador Pedraza; Christian Gerloff
Journal:  N Engl J Med       Date:  2018-05-16       Impact factor: 91.245

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.